Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Wang SV"'
Autor:
Wang SV, Schneeweiss S
Publikováno v:
Clinical Epidemiology, Vol Volume 14, Pp 601-608 (2022)
Shirley V Wang, Sebastian Schneeweiss Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USACorrespondence: Shirley V Wang, Brigham and Women’s Hospital, Harvard Medical School, 1620 Tremont St, Suite 303, Boston, MA, 02120, USA, T
Externí odkaz:
https://doaj.org/article/a6fc81fc8afd446abff22eecb3834a91
Autor:
Lee MP, Glynn RJ, Schneeweiss S, Lin KJ, Patorno E, Barberio J, Levin R, Evers T, Wang SV, Desai RJ
Publikováno v:
Clinical Epidemiology, Vol Volume 12, Pp 607-616 (2020)
Moa P Lee,1,2 Robert J Glynn,1 Sebastian Schneeweiss,1 Kueiyu Joshua Lin,1,3 Elisabetta Patorno,1 Julie Barberio,1 Raisa Levin,1 Thomas Evers,4 Shirley V Wang,1 Rishi J Desai1 1Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women
Externí odkaz:
https://doaj.org/article/61c52b98e56e4a32a631234e749c4224
Publikováno v:
In Value in Health May 2016 19(3):A75-A75
Autor:
Gagne, JJ, Han, X, Hennessy, S, Leonard, CE, Chrischilles, EA, Carnahan, RM, Wang, SV, Fuller, C, Iyer, A, Katcoff, H, Woodworth, TS, Archdeacon, P, Meyer, TE, Schneeweiss, S, Toh, S
Publikováno v:
Clinical Pharmacology & Therapeutics; Nov2016, Vol. 100 Issue 5, p558-564, 7p
Publikováno v:
Clinical Pharmacology & Therapeutics; Mar2016, Vol. 99 Issue 3, p325-332, 8p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wang SV; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA 02120, United States.; Department of Medicine, Harvard Medical School, Boston, MA 02115, United States., Pottegård A; Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, Faculty of Health Sciences, University of Southern Denmark, 5230 Odense M, Denmark.
Publikováno v:
American journal of epidemiology [Am J Epidemiol] 2024 Nov 04; Vol. 193 (11), pp. 1625-1631.
Autor:
Wyss R; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02120, United States., van der Laan M; Division of Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, CA 94720, United States., Gruber S; Putnam Data Sciences, LLC, Cambridge, MA 02139, United States., Shi X; Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI 48109, United States., Lee H; Office of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20903, United States., Dutcher SK; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20903, United States., Nelson JC; Kaiser Permanente Washington Health Research Institute, Seattle, WA 98101, United States., Toh S; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA 02215, United States., Russo M; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02120, United States., Wang SV; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02120, United States., Desai RJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02120, United States., Lin KJ; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02120, United States.
Publikováno v:
American journal of epidemiology [Am J Epidemiol] 2024 Nov 04; Vol. 193 (11), pp. 1632-1640.
Autor:
Rivera DR; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Eckert JC; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Rodriguez-Watson C; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Lerro CC; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Bertagnolli MM; Alliance for Clinical Trials in Oncology, Brigham & Women's Hospital, Boston, Massachusetts, USA., Hubbard RA; Department of Biostatistics, Epidemiology & Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kushi LH; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA., Lund JL; Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Schrag D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Wang SV; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Wood WA; Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Lee JJ; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Okafor C; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Ghauri K; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Winckler SC; Reagan-Udall Foundation for the Food and Drug Administration, Washington, DC, USA., Kluetz PG; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Publikováno v:
Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Nov; Vol. 33 (11), pp. e5818.
Autor:
Tan GSQ; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Australia.; Baker Heart and Diabetes Institute, Melbourne, Australia., Maro JC; Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute, Boston, MA, USA., Wang SV; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Toh S; Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Morton JI; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Australia.; Baker Heart and Diabetes Institute, Melbourne, Australia., Ilomäki J; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Australia., Wong J; Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute, Boston, MA, USA., Li X; Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Publikováno v:
American journal of epidemiology [Am J Epidemiol] 2024 Sep 11. Date of Electronic Publication: 2024 Sep 11.